Ultrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo.
Replication-competent forms of herpes simplex virus 1 (HSV-1) defective in the viral neurovirulence factor infected cell protein 34.5 (ICP34.5) are under investigation for use in the therapeutic treatment of cancer. In mouse models, intratumoral injection of ICP34.5-defective oncolytic HSVs (oHSVs) has resulted in the infection and lysis of tumor cells, an associated decrease in tumor size, and increased survival times. The ability of these oHSVs to infect and lyse cells is frequently characterized as exclusive to or selective for tumor cells. However, the extent to which ICP34.5-deficient HSV-1 replicates in and may be neurotoxic to normal brain cell types in vivo is poorly understood. Here we report that HSV-1 defective in ICP34.5 expression is capable of establishing a productive infection in at least one normal mouse brain cell type. We show that γ34.5 deletion viruses replicate productively in and induce cellular damage in infected ependymal cells. Further evaluation of the effects of oHSVs on normal brain cells in animal models is needed to enhance our understanding of the risks associated with the use of current and future oHSVs in the brains of clinical trial subjects and to provide information that can be used to create improved oHSVs for future use.
Mehta
Hina
H
Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA.
Muller
Jacqueline
J
Markovitz
Nancy S
NS
D000818:Animals; D001921:Brain / Q000473:pathology / Q000821:virology*; D003673:Defective Viruses / Q000472:pathogenicity* / Q000648:ultrastructure; D017353:Gene Deletion; D006561:Herpes Simplex; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000472:pathogenicity*; D051379:Mice; D050130:Oncolytic Virotherapy; D050504:Oncolytic Viruses / Q000235:genetics; D014764:Viral Proteins / Q000235:genetics*; D014779:Virus Replication
D014764:Viral Proteins; C066469:gamma 34.5 protein, Human herpesvirus 1